Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
February 02, 2023 08:00 ET
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Announces Granting of New Hire Inducement Award
January 27, 2023 16:30 ET
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development...
Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
January 09, 2023 08:00 ET
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation
December 21, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global...
TJP Labs Inc. Amends Its Drug Establishment License and Achieves Approval for Active Pharmaceutical Ingredients
November 17, 2022 15:04 ET
|
TJP Labs Inc.
PICKERING, Ontario, Nov. 17, 2022 (GLOBE NEWSWIRE) -- TJP Labs Inc. ("TJP Labs") is North America's leading full-service contract manufacturer of premier next-generation products, focusing on modern...
Global Nicotine Pouches Market Will Turn over USD 26033.84 million to success Revenue to Cross USD 33773.51 million in 2022 to 2027 Top Companies report covers, consumption by Regional data
November 17, 2022 03:18 ET
|
Proficient Market Insights
Pune, Nov. 17, 2022 (GLOBE NEWSWIRE) -- "Nicotine Pouches Market" research report focus on overall information that can help to take decisions on current market situation. Vaping, smokeless,...
Achieve Life Sciences Announces Private Placement of $18.9 Million
November 15, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Reports Financial Results for Third Quarter 2022 and Provides Corporate Update
November 14, 2022 16:05 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial
November 08, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022
October 31, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...